Economists, Docs Back Actavis In Namenda Injunction Row

A slew of economists, physicians and drug industry groups have urged the Second Circuit to overturn the New York attorney general's injunction requiring Actavis PLC to continue selling a version of...

Already a subscriber? Click here to view full article